Abstract:OBJECTIVE:To investigate the expression of fascin and cytokeratin 14 (CK14) in human esophageal squamous cell carcinoma (ESCC) and the association of these two proteins with ESCC malignant progression and the possibility of application of these 2 proteins in the diagnosis of ESCC.METHODS:A tissue microarray composed of the representative regions of ESCC and corresponding normal epithelium was constructed. Immunohistochemistry was conducted to examine the expression of fascin and CD14 in 116 specimens of ESCC and the normal tissues near the cancerous tissues. The relation of these two proteins with the invasive depth, node involvement, differentiated grade, pTNM stages was analyzed. Disease-free survival analysis was carried out using Kaplan-Meier method. The correlation of the two proteins was analyzed using Spearman's correlation test. ESCC cells of the lines EC9706, TE12, COLO-680N, KYSE510, KYSE450, KYSE410, KYSE180, KYSE150, KYSE140, KYSE70, KYSE30, and YES2 were cultured and underwent SDS-PAGE and Western blotting to examine the expression of fascin and CD14. And the correlation of the two proteins with the characteristics of the cell lines was analyzed too.RESULTS:Fascin and CK14 were negative in the normal esophageal epithelia except in the basal cells. The positive rates of fascin and CK14 in the ESCC cells were 79.3% and 67.0% respectively. The positive rate of either fascin or CK14 was 86.2%. The expression rates of fascin and CK14 in well- and moderately-differentiated ESCCs were significantly higher than that in the poorly-differentiated ones (P = 0.054 and P < 0.01). The patients with positive expression of fascin and those with negative expression of CK14 had a poorer survival in comparison with those with negative fascin expression and those with positive CK14 expression respectively, however, without statistical significances (P = 0.8980 and P = 0.2610). The positive rates of fascin in the well-, moderately-, and poorly- differentiated ESCCs were 87.1%, 83.9%, and 62.1% respectively (P = 0.054). The positive rates of CK14 in the well-, moderately-, and poorly-differentiated ESCCs were; 87.1%, 76.4%, and 27.6% respectively (P < 0.01). The prognosis was not significantly correlated with the expression of both proteins (P = 0.8980 and P = 0.2610). There was an significantly positive correlation between the expression levels of these 2 proteins (r = 0.487, P < 0.01). Fascin was highly expressed in most of the ESCC lines, except in the slowly growing and weakly migrating TE12 line. High expression of CK14 was only seen in the line KYSE180.CONCLUSION:Fascin and CK14 may play important roles in the carcinogenesis and progression of ESCC. Combination of fascin and CK14 would be valuable markers in diagnosis of ESCC.

Correlation of CTSD, P63, and Ki67 Expressions with Risk Assessment of Oesophageal Squamous-Cell Carcinoma

[Expression of Fascin and Cytokeratin 14 in Esophageal Squamous Cell Carcinoma].

[Expression of Fas, Fas Ligand, Fas-associated Death Domain Protein, Caspase 8 and Mutant P53 Protein in Esophageal Squamous Cell Carcinoma].

Expression of P-EGFR and P-Akt Protein in Esophageal Squamous Cell Carcinoma and Its Prognosis

Correlation Between Secreted Protein Acidic and Rich in Cysteine Protein Expression and the Prognosis of Postoperative Patients Exhibiting Esophageal Squamous Cell Carcinoma

Characterization and correlation of 14-3-3σ and P53 protein expressions in multi-stage carcinogenesis of esophageal squamous cell carcinoma

Tissue Microarray Analysis Reveals a Tight Correlation Between Protein Expression Pattern and Progression of Esophageal Squamous Cell Carcinoma

Expressions of Oct4 and Sox2 Protein and Their Correlations in Esophageal Squamous Cell Carcinoma

Abnormal P16 Expression and Prognostic Significance in Esophageal Squamous Cell Carcinoma.

Expression of CDC2,CLDN5 and its clinical significance in esophageal squamous cell carcinoma

Expression and Clinical Significance of Survivin and P63 Protein in Esophageal Squamous Carcinoma

Expressions of p-EGFR and p-Akt proteins in esophageal squamous cell carcinoma tissue

Expression of EGFR,GST-π and C-erbB-2 in esophageal squamous cell carcinoma and their clinical significance

[A Histopathologic and Immunohistochemical Study of Prognostic Factors in Esophageal Squamous Cell Carcinoma].

Elevated P53 Expression Levels Correlate with Tumor Progression and Poor Prognosis in Patients Exhibiting Esophageal Squamous Cell Carcinoma.

Expression of VEGF-C correlates with a poor prognosis based on analysis of prognostic factors in 73 patients with esophageal squamous cell carcinomas.

Quantitative immunohistochemistry (IHC) analysis of biomarker combinations for human esophageal squamous cell carcinoma

Combined assessment of tumour cell nest size and desmoplastic reaction as an excellent prognostic predictor in oesophageal squamous cell carcinoma

Comparative Proteomic Analysis of Esophageal Squamous Cell Carcinoma

A Panel Of Overexpressed Proteins For Prognosis In Esophageal Squamous Cell Carcinoma

Expression and Clinical Significance of HIF-1α, VEGF and Survivin in Esophageal Squamous Cell Carcinoma